Table 4.
Infants (12 weeks–11 months) | Toddlers (12–35 months) | Children (3–9 years) | Adolescents (10–17 years) | Adults (18–64 years) | The elderly (≥ 65 years) | |
---|---|---|---|---|---|---|
Regulatory maximum level exposure assessment scenario | ||||||
Mean | 40.7–244.6 | 122.6–521.6 | 116.8–412.5 | 76.2–280.8 | 47.8–193.6 | 42.1–170.5 |
95th percentile | 95.3–793.3 | 299.7–842.1 | 241.7–705.5 | 153.0–477.9 | 105.2–375.9 | 90.9–299.5 |
Refined estimated exposure assessment scenario | ||||||
Brand‐loyal scenario | ||||||
Mean | 0.001–0.007 | 0.006–0.030 | 0.009–0.034 | 0.004–0.022 | 0.004–0.014 | 0.003–0.011 |
95th percentile | 0.006–0.028 | 0.024–0.059 | 0.025–0.064 | 0.013–0.048 | 0.011–0.031 | 0.009–0.023 |
Non‐brand‐loyal scenario | ||||||
Mean | < 0.001–0.004 | 0.003–0.015 | 0.005–0.033 | 0.002–0.022 | 0.002–0.008 | 0.002–0.006 |
95th percentile | 0.003–0.015 | 0.013–0.044 | 0.013–0.063 | 0.007–0.048 | 0.006–0.024 | 0.005–0.016 |